Northwestern Mutual Wealth Management Co. acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,615 shares of the semiconductor company's stock, valued at approximately $6,965,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of SNPS. Sankala Group LLC bought a new stake in shares of Synopsys in the fourth quarter worth $25,000. Elevation Wealth Partners LLC grew its position in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 27 shares in the last quarter. IMG Wealth Management Inc. bought a new position in Synopsys in the second quarter valued at $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys in the 4th quarter valued at $28,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in Synopsys in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 85.47% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have commented on SNPS shares. Wells Fargo & Company cut their price target on shares of Synopsys from $535.00 to $450.00 and set an "equal weight" rating on the stock in a research report on Tuesday, August 11th. Stifel Nicolaus lifted their target price on Synopsys from $550.00 to $600.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. Zacks Research upgraded Synopsys from a "hold" rating to a "strong-buy" rating in a report on Tuesday, June 30th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Synopsys in a report on Monday, June 8th. Finally, Bank of America increased their price target on Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and an average target price of $563.59.
Get Our Latest Research Report on SNPS
Synopsys Stock Performance
Shares of SNPS opened at $397.87 on Monday. The firm has a 50-day moving average of $419.73 and a 200-day moving average of $440.09. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79. The company has a market cap of $76.18 billion, a PE ratio of 92.10, a price-to-earnings-growth ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys's revenue was up 41.9% on a year-over-year basis. During the same period last year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company's stock, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.